688399 硕世生物
已收盘 08-24 15:00:01
资讯
新帖
简况
每周股票复盘：硕世生物（688399）股东户数减少1.57%，户均持股市值40.01万元
证券之星 · 08-23 03:30
每周股票复盘：硕世生物（688399）股东户数减少1.57%，户均持股市值40.01万元
硕世生物(688399)8月10日股东户数0.92万户，较上期减少1.57%
证券之星 · 08-17
硕世生物(688399)8月10日股东户数0.92万户，较上期减少1.57%
硕世生物：截至2026年8月10日，公司股东总数9,234户
证券之星 · 08-17
硕世生物：截至2026年8月10日，公司股东总数9,234户
每周股票复盘：硕世生物（688399）实控人变更为房永生
证券之星 · 08-02
每周股票复盘：硕世生物（688399）实控人变更为房永生
硕世生物（688399）披露实际控制人变更公告，7月29日股价下跌0.48%
证券之星 · 07-29
硕世生物（688399）披露实际控制人变更公告，7月29日股价下跌0.48%
上交所向硕世生物下发监管工作函
格隆汇 · 07-29
上交所向硕世生物下发监管工作函
股市必读：硕世生物（688399）7月23日董秘有最新回复
证券之星 · 07-24
股市必读：硕世生物（688399）7月23日董秘有最新回复
硕世生物：截至2026年7月20日，公司股东总数9,381户
证券之星 · 07-23
硕世生物：截至2026年7月20日，公司股东总数9,381户
每周股票复盘：硕世生物（688399）现折价19.63%大宗交易
证券之星 · 07-19
每周股票复盘：硕世生物（688399）现折价19.63%大宗交易
股市必读：7月15日硕世生物现1笔折价19.63%的大宗交易 合计成交292.4万元
证券之星 · 07-16
股市必读：7月15日硕世生物现1笔折价19.63%的大宗交易 合计成交292.4万元
每周股票复盘：硕世生物（688399）拟每股转增0.48股
证券之星 · 07-05
每周股票复盘：硕世生物（688399）拟每股转增0.48股
股市必读：硕世生物（688399）7月2日董秘有最新回复
证券之星 · 07-03
股市必读：硕世生物（688399）7月2日董秘有最新回复
硕世生物（688399）披露2025年年度权益分派实施公告，7月2日股价上涨0.13%
证券之星 · 07-02
硕世生物（688399）披露2025年年度权益分派实施公告，7月2日股价上涨0.13%
每周股票复盘：硕世生物（688399）股东户数减少4.04%，户均持股上升
证券之星 · 06-28
每周股票复盘：硕世生物（688399）股东户数减少4.04%，户均持股上升
硕世生物（688399）披露2025年年度股东会决议公告，6月25日股价下跌4.53%
证券之星 · 06-25
硕世生物（688399）披露2025年年度股东会决议公告，6月25日股价下跌4.53%
硕世生物：截至2026年6月18日，公司股东总数8,631户
证券之星 · 06-23
硕世生物：截至2026年6月18日，公司股东总数8,631户
硕世生物：截至2026年6月10日，公司股东总数8,994户
证券之星 · 06-11
硕世生物：截至2026年6月10日，公司股东总数8,994户
硕世生物(688399.SH)取得医疗器械注册证
智通财经 · 05-06
硕世生物(688399.SH)取得医疗器械注册证
股市必读：硕世生物(688399)股东户数0.85万户，较上期增加3.3%
证券之星 · 05-06
股市必读：硕世生物(688399)股东户数0.85万户，较上期增加3.3%
每周股票复盘：硕世生物（688399）股东户数增3.3%
证券之星 · 05-02
每周股票复盘：硕世生物（688399）股东户数增3.3%
加载更多
公司概况
公司名称：
江苏硕世生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2019-12-05
主营业务：
江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是诊断试剂、诊断仪器、检测服务。
发行价格：
46.78
{"stockData":{"symbol":"688399","market":"SH","secType":"STK","nameCN":"硕世生物","latestPrice":27.85,"timestamp":1787554801000,"preClose":28.64,"halted":0,"volume":1789511,"delay":0,"changeRate":-0.0276,"floatShares":124000000,"shares":124000000,"eps":-0.2641,"marketStatus":"已收盘","change":-0.79,"latestTime":"08-24 15:00:01","open":28.64,"high":28.82,"low":27.56,"amount":50095000,"amplitude":0.044,"askPrice":27.86,"askSize":5,"bidPrice":27.85,"bidSize":145,"shortable":0,"etf":0,"ttmEps":-0.2641,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787621400000},"marketStatusCode":5,"adr":0,"adjPreClose":28.64,"symbolType":"stock_kcb","openAndCloseTimeList":[[1787535000000,1787542200000],[1787547600000,1787554800000]],"highLimit":31.5,"lowLimit":25.78,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":124130147,"isCdr":false,"pbRate":1.17,"roa":"--","roe":"0.72%","epsLYR":-0.49,"committee":0.409894,"marketValue":3457000000,"turnoverRate":0.0144,"status":1,"afterMarket":{"amount":0,"volume":0,"close":27.85,"buyVolume":0,"sellVolume":0,"time":1787556837746,"indexStatus":"已收盘 08-24 15:30:00","preClose":28.64},"floatMarketCap":3457000000},"requestUrl":"/m/hq/s/688399","defaultTab":"news","newsList":[{"id":"2661312214","title":"每周股票复盘：硕世生物（688399）股东户数减少1.57%，户均持股市值40.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661312214","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661312214?lang=zh_cn&edition=full","pubTime":"2026-08-23 03:30","pubTimestamp":1787427032,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，硕世生物报收于28.64元，较上周的29.95元下跌4.37%。本周，硕世生物8月20日盘中最高价报30.6元。8月19日盘中最低价报28.21元。硕世生物当前最新总市值35.55亿元，在医疗器械板块市值排名92/129，在两市A股市值排名3934/5210。本周关注点股本股东变化：股东户数减少1.57%，户均持股市值达40.01万元股本股东变化股东户数变动截至2026年8月10日，硕世生物股东户数为9234.0户，较7月20日减少147.0户，减幅1.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660486241","title":"硕世生物(688399)8月10日股东户数0.92万户，较上期减少1.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660486241","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660486241?lang=zh_cn&edition=full","pubTime":"2026-08-17 17:35","pubTimestamp":1786959335,"startTime":"0","endTime":"0","summary":"证券之星消息，近日硕世生物披露，截至2026年8月10日公司股东户数为9234.0户，较7月20日减少147.0户，减幅为1.57%。户均持股数量由上期的1.32万股增加至1.34万股，户均持股市值为40.01万元。在医疗器械行业个股中，硕世生物股东户数低于行业平均水平，截至8月10日，医疗器械行业平均股东户数为2.15万户。根据统计，硕世生物2026年7月20日至2026年8月10日，主力资金净流出7096.56万元，游资资金净流入1981.79万元，散户资金净流入5114.77万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700023154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483032","title":"硕世生物：截至2026年8月10日，公司股东总数9,234户","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660483032?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:36","pubTimestamp":1786955774,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物(688399)08月17日在投资者关系平台上答复投资者关心的问题。投资者提问：你好！请问8月10日公司的股东人数是多少？谢谢硕世生物回复：尊敬的投资者您好，根据中登公司最新下发的股东名册，截至2026年8月10日，公司股东总数9,234户。感谢您的关注!本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700020905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656431665","title":"每周股票复盘：硕世生物（688399）实控人变更为房永生","url":"https://stock-news.laohu8.com/highlight/detail?id=2656431665","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656431665?lang=zh_cn&edition=full","pubTime":"2026-08-02 01:51","pubTimestamp":1785606672,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，硕世生物报收于26.19元，较上周的26.27元下跌0.3%。公司实际控制人由三人变更为房永生。控股股东绍兴闰康生物医药股权投资合伙企业目前处于涉诉状态，存在解散风险，可能导致实际控制人进一步变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655226899","title":"硕世生物（688399）披露实际控制人变更公告，7月29日股价下跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655226899","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655226899?lang=zh_cn&edition=full","pubTime":"2026-07-29 22:38","pubTimestamp":1785335899,"startTime":"0","endTime":"0","summary":"截至2026年7月29日收盘，硕世生物报收于26.74元，较前一交易日下跌0.48%，最新总市值为33.19亿元。该股当日开盘26.99元，最高27.39元，最低26.38元，成交额达4482.63万元，换手率为1.35%。公司实际控制人由三人变更为房永生。控股股东绍兴闰康生物医药股权投资合伙企业目前处于涉诉状态，存在解散风险，可能导致实际控制人进一步变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900040730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655864625","title":"上交所向硕世生物下发监管工作函","url":"https://stock-news.laohu8.com/highlight/detail?id=2655864625","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655864625?lang=zh_cn&edition=full","pubTime":"2026-07-29 19:05","pubTimestamp":1785323143,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653272246","title":"股市必读：硕世生物（688399）7月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653272246","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653272246?lang=zh_cn&edition=full","pubTime":"2026-07-24 01:02","pubTimestamp":1784826137,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘，硕世生物报收于27.84元，下跌2.76%，换手率1.92%，成交量2.38万手，成交额6631.89万元。谢谢董秘： 尊敬的投资者您好，根据中登公司最新下发的股东名册，截至2026年7月20日，公司股东总数9,381户。当日关注点交易信息汇总：7月23日主力资金净流出1205.07万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400000895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653290746","title":"硕世生物：截至2026年7月20日，公司股东总数9,381户","url":"https://stock-news.laohu8.com/highlight/detail?id=2653290746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653290746?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:09","pubTimestamp":1784801354,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物(688399)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年7月20日公司股东人数是多少？谢谢硕世生物回复：尊敬的投资者您好，根据中登公司最新下发的股东名册，截至2026年7月20日，公司股东总数9,381户。感谢您的关注!本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300037523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230291","title":"每周股票复盘：硕世生物（688399）现折价19.63%大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652230291?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:54","pubTimestamp":1784400851,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，硕世生物报收于31.5元，较上周的32.29元下跌2.45%。本周，硕世生物7月16日盘中最高价报37.37元。7月14日盘中最低价报30.21元。硕世生物当前最新总市值39.1亿元，在医疗器械板块市值排名80/129，在两市A股市值排名3538/5199。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651495292","title":"股市必读：7月15日硕世生物现1笔折价19.63%的大宗交易 合计成交292.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651495292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651495292?lang=zh_cn&edition=full","pubTime":"2026-07-16 04:13","pubTimestamp":1784146388,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，硕世生物报收于33.47元，上涨5.98%，换手率2.68%，成交量3.33万手，成交额1.11亿元。交易信息汇总资金流向7月15日主力资金净流出6.6万元；游资资金净流出43.02万元；散户资金净流入49.61万元。大宗交易7月15日硕世生物现1笔折价19.63%的大宗交易，合计成交292.4万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600004530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649207694","title":"每周股票复盘：硕世生物（688399）拟每股转增0.48股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649207694","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649207694?lang=zh_cn&edition=full","pubTime":"2026-07-05 02:54","pubTimestamp":1783191250,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，硕世生物报收于48.07元，较上周的43.98元上涨9.3%。本周，硕世生物7月3日盘中最高价报48.36元。本周关注点公司公告汇总：硕世生物拟以资本公积金向全体股东每股转增0.48股。公司公告汇总江苏硕世生物科技股份有限公司发布2025年年度权益分派实施公告，将以资本公积金向全体股东每股转增0.48股，不涉及差异化分红送转。股权登记日为2026年7月9日，除权（息）日与新增无限售条件流通股份上市日为2026年7月10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648741680","title":"股市必读：硕世生物（688399）7月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648741680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648741680?lang=zh_cn&edition=full","pubTime":"2026-07-03 03:30","pubTimestamp":1783020633,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，硕世生物报收于45.48元，上涨0.13%，换手率1.47%，成交量1.23万手，成交额5664.34万元。公司公告汇总：硕世生物拟于2026年7月10日实施每股转增0.48股的资本公积金转增股本，转增后总股本由83,871,721股增至124,130,147股。股权登记日为2026年7月9日，除权（息）日与新增无限售条件流通股份上市日为2026年7月10日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300004944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648862266","title":"硕世生物（688399）披露2025年年度权益分派实施公告，7月2日股价上涨0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648862266","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648862266?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:58","pubTimestamp":1783004295,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，硕世生物报收于45.48元，较前一交易日上涨0.13%，最新总市值为38.14亿元。近日，江苏硕世生物科技股份有限公司发布《2025年年度权益分派实施公告》，以资本公积金向全体股东每股转增0.48股，不涉及差异化分红送转。股权登记日为2026年7月9日，除权（息）日与新增无限售条件流通股份上市日为2026年7月10日。本次转增股本由中国结算上海分公司按股权登记日登记在册股东持股数直接计入账户，不涉及扣税情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646131315","title":"每周股票复盘：硕世生物（688399）股东户数减少4.04%，户均持股上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2646131315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646131315?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:30","pubTimestamp":1782588634,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，硕世生物报收于43.98元，较上周的49.35元下跌10.88%。本周，硕世生物6月23日盘中最高价报50.8元。股本股东变化股东户数变动截至2026年6月18日，硕世生物股东户数为8631.0户，较6月10日减少363.0户，减幅为4.04%。公司公告汇总上海市通力律师事务所关于江苏硕世生物科技股份有限公司2025年年度股东会的法律意见书上海市通力律师事务所就硕世生物2025年年度股东会的召集召开程序、出席人员资格、表决程序及表决结果出具法律意见。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800001064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646876266","title":"硕世生物（688399）披露2025年年度股东会决议公告，6月25日股价下跌4.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646876266","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646876266?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:37","pubTimestamp":1782380251,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，硕世生物报收于45.36元，较前一交易日下跌4.53%，最新总市值为38.04亿元。公司于近日披露《江苏硕世生物科技股份有限公司2025年年度股东会决议公告》。公告显示，硕世生物于2026年6月24日召开2025年年度股东会，会议由董事会召集，董事长王国强主持，采用现场与网络投票结合方式召开。出席会议股东共63人，代表有表决权股份37,355,149股，占公司总股本的44.5384%。所有议案均获通过，无否决议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500032236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645889238","title":"硕世生物：截至2026年6月18日，公司股东总数8,631户","url":"https://stock-news.laohu8.com/highlight/detail?id=2645889238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645889238?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:18","pubTimestamp":1782202701,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物(688399)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年6月20日公司的股东总数是多少？谢谢硕世生物回复：尊敬的投资者您好，根据中登公司最新下发的股东名册，截至2026年6月18日，公司股东总数8,631户。感谢您的关注!本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300026895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642128887","title":"硕世生物：截至2026年6月10日，公司股东总数8,994户","url":"https://stock-news.laohu8.com/highlight/detail?id=2642128887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642128887?lang=zh_cn&edition=full","pubTime":"2026-06-11 17:15","pubTimestamp":1781169324,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物(688399)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至2026年6月10日，公司股东人数是多少？硕世生物回复：尊敬的投资者您好，根据中登公司最新下发的股东名册，截至2026年6月10日，公司股东总数8,994户。感谢您的关注!本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100027121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633185865","title":"硕世生物(688399.SH)取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2633185865","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633185865?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:48","pubTimestamp":1778060883,"startTime":"0","endTime":"0","summary":"智通财经APP讯，硕世生物(688399.SH)发布公告，公司近日收到国家药品监督管理局签发的医疗器械注册证(体外诊断试剂)，产品名称：甲型H1N1(2009)和季节性H3亚型流感病毒核酸检测试剂盒(荧光PCR法)，该试剂盒用于体外定性检测人咽拭子样本中甲型H1N1(2009)和季节性H3亚型流感病毒核酸。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438595.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","688399","BK0239","159883","BK1100","09997","BK1574","BK1583","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633992220","title":"股市必读：硕世生物(688399)股东户数0.85万户，较上期增加3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633992220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633992220?lang=zh_cn&edition=full","pubTime":"2026-05-06 05:05","pubTimestamp":1778015116,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，硕世生物报收于61.75元，上涨1.73%，换手率1.66%，成交量1.4万手，成交额8667.58万元。当日关注点来自交易信息汇总：4月30日主力资金净流出532.11万元，占总成交额6.14%。股本股东变化股东户数变动近日硕世生物披露，截至2026年4月10日公司股东户数为8459.0户，较3月31日增加270.0户，增幅为3.3%。户均持股数量由上期的1.02万股减少至9915.0股，户均持股市值为51.43万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632446628","title":"每周股票复盘：硕世生物（688399）股东户数增3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632446628","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632446628?lang=zh_cn&edition=full","pubTime":"2026-05-02 05:31","pubTimestamp":1777671074,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，硕世生物报收于61.75元，较上周的60.97元上涨1.28%。本周，硕世生物4月28日盘中最高价报63.63元。硕世生物当前最新总市值51.79亿元，在医疗器械板块市值排名73/129，在两市A股市值排名3398/5200。股本股东变化股东户数变动截至2026年4月10日，硕世生物股东户数为8459.0户，较3月31日增加270.0户，增幅3.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787604284831,"stockEarnings":[{"period":"1week","weight":-0.0623},{"period":"1month","weight":0.0601},{"period":"3month","weight":-0.2607},{"period":"6month","weight":-0.3494},{"period":"1year","weight":-0.3158},{"period":"ytd","weight":-0.3983}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":0.0178},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.064},{"period":"1year","weight":0.0147},{"period":"ytd","weight":-0.0219}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏硕世生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"9234人(较上一季度减少1.57%)","perCapita":"13442股","listingDate":"2019-12-05","address":"江苏省泰州市海陵区药城大道837号","registeredCapital":"12413万元","survey":" 江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是诊断试剂、诊断仪器、检测服务。","listedPrice":46.78},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"硕世生物,688399,硕世生物股票,硕世生物股票老虎,硕世生物股票老虎国际,硕世生物行情,硕世生物股票行情,硕世生物股价,硕世生物股市,硕世生物股票价格,硕世生物股票交易,硕世生物股票购买,硕世生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}